首页> 外文期刊>Journal of drug targeting >Inverse targeting of diclofenac sodium to reticuloendothelial system-rich organs by sphere-in-oil-in-water (s/o/w) multiple emulsion containing poloxamer 403.
【24h】

Inverse targeting of diclofenac sodium to reticuloendothelial system-rich organs by sphere-in-oil-in-water (s/o/w) multiple emulsion containing poloxamer 403.

机译:通过含有泊洛沙姆403的水包油包水(s / o / w)多重乳剂将双氯芬酸钠逆向富含网状内皮系统的器官靶向。

获取原文
获取原文并翻译 | 示例
       

摘要

Sphere-in-oil-in-water (s/o/w) multiple emulsions containing diclofenac sodium were prepared by gelatinization of inner aqueous phase. A further modified version (s/o/wp) of s/o/w was formulated by adding 5.0% w/v poloxamer 403 to the external aqueous phase during the second step of emulsification in order to affect the adsorptive coating on the surface (s/o/wp). The inverse targeting of reticuloendothelial system (RES) rich organs was compared with a non reticuloendothelial system after intravenous administration of s/o/w multiple emulsion (treatment I) and poloxamer containing s/o/wp multiple emulsion (treatment II). The amount of diclofenac sodium in the plasma and various organs was measured to elucidate the effect of inverse targeting to RES and targeting to other tissues in terms of the incorporated drug. After i.v. administration, the half life (34.65 vs.16.26?h) and apparent volume of distribution of diclofenac sodium (2815 vs. 1671.5?ml/kg) were significantly higher in treatment II than in treatment I. It is concluded that the amount of drug in RES rich organs (spleen, liver) were significantly lower than the values in non-RES organs such as lungs, inflammatory tissue (synovial fluid) in treatment II than in treatment I.
机译:通过内水相的糊化制备含有双氯芬酸钠的水包油球状(s / o / w)多重乳液。通过在乳化第二步中向外部水相中添加5.0%w / v泊洛沙姆403来配制s / o / w的另一种改进版本(s / o / wp),以影响表面的吸附涂层( s / o / wp)。在静脉内施用s / o / w多重乳剂(治疗I)和含s / o / wp多重乳剂的泊洛沙姆(治疗II)后,将富网状内皮系统(RES)器官的反向靶向与非网状内皮系统进行了比较。测量血浆和各种器官中双氯芬酸钠的量以阐明就掺入的药物而言,反向靶向RES和靶向其他组织的作用。在i.v.之后给药后,治疗II的半衰期(34.65 vs.16.26?h)和双氯芬酸钠的表观分布体积(2815 vs. 1671.5?ml / kg)显着高于治疗I。结论是药物用量与治疗I相比,治疗II中RES丰富器官(脾脏,肝脏)的含量显着低于非RES器官如肺,炎性组织(滑液)的值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号